Trevi Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Trevi Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2018 to Q2 2024.
  • Trevi Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 72.6M shares, a 15% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 72.6M +9.49M +15% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 69M +8.89M +14.8% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 68.3M +8.34M +13.9% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 63.9M +5.53M +9.49% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 63.1M +23.4M +58.9% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 60.1M +29.3M +95% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 59.9M +31.4M +110% Dec 31, 2022 10-K 2024-03-20
Q3 2022 58.3M +39.8M +214% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 39.7M +18.3M +85.1% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 30.8M +10.9M +54.7% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 28.5M +9.96M +53.7% Dec 31, 2021 10-K 2023-03-16
Q3 2021 18.5M +226K +1.23% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 21.5M +3.61M +20.2% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 19.9M +2.08M +11.7% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 18.5M +712K +3.99% Dec 31, 2020 10-K 2022-03-17
Q3 2020 18.3M +486K +2.73% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 17.9M +16.6K +0.09% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 17.8M +17.4M +3966% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 17.8M +17.4M +3966% Dec 31, 2019 10-K 2021-03-25
Q3 2019 17.8M Sep 30, 2019 10-Q 2019-11-14
Q2 2019 17.8M Jun 30, 2019 10-Q 2019-08-12
Q1 2019 439K Mar 31, 2019 10-Q 2019-06-14
Q4 2018 439K Dec 31, 2018 10-K 2020-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.